FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

404 letters match. Newest first.

  1. All American Wellness

    FDA warned telehealth seller All American Wellness that its website wrongly compares compounded semaglutide and tirzepatide to Ozempic and Mounjaro.

    Low
  2. Healthy Male

    FDA warns Healthy Male that its website sells compounded tirzepatide with false or misleading 'clinically proven' weight-loss claims.

    Low
  3. Intimate Rose

    FDA warned Intimate Rose that its website sells compounded semaglutide and tirzepatide with misleading claims that they match approved drugs.

    High risk
  4. Invigorate Med Spa

    Invigorate Med Spa's website claimed compounded semaglutide and tirzepatide were Wegovy and Mounjaro, making them misbranded.

    Low
  5. Dr. Gater’s Weight Loss & Wellness

    Dr. Gater’s Weight Loss & Wellness marketed compounded semaglutide and tirzepatide with false or misleading FDA-approval and generic-Ozempic claims.

    Medium
  6. Remedy Meds

    FDA warns Remedy Meds that its telehealth site misleadingly labels pharmacy-made semaglutide and tirzepatide with approved-drug comparisons.

    Low
  7. EA WORKS Limited Liability Company dba Trust Labs

    FDA warned Trust Labs it sold unapproved compounded retatrutide and made false FDA-approval claims for semaglutide and tirzepatide online.

    High risk
  8. Fancy Meds, LLC dba Fancy Meds

    FDA warns Fancy Meds that its compounded semaglutide and tirzepatide website claims are false or misleading.

    Low
  9. Matthew Stern, CEO MyStart Health LLC.

    FDA warns MyStart Health over 'Generic Ozempic' claims for compounded semaglutide.

    Low
  10. Elite Health Center

    FDA warned Elite Health Center that its website falsely implied compounded semaglutide was FDA-approved, making the drugs misbranded.

    Low
  11. Curex

    FDA warned Curex that its website ads for compounded semaglutide and tirzepatide are false or misleading.

    High risk
  12. Healthon Inc. dba Healthon

    FDA warned Healthon over unapproved compounded semaglutide and tirzepatide sold online with false 'FDA-approved' and 'same as' claims.

    High risk
  13. www.usaquickmeds.com

    FDA warned usaquickmeds.com for selling unapproved and misbranded opioids and benzodiazepines online without prescriptions.

    High risk
  14. Vacation Inc.

    FDA warned Vacation Inc. that its whipped-cream-style sunscreen mousses are unapproved drugs and that their food-like cans are misleading.

    High risk
  15. Kalani AB dba Kalani Sunwear

    FDA warns Kalani AB that its Sun Mousse SPF 50 sunscreen is an unapproved, misbranded drug for US sale.

    High risk
  16. Fallien Cosmeceuticals Ltd. dba Fallene Ltd.

    FDA warns Fallien over unapproved OTC sunscreen foam TiZO SHEERFOAM SPF 30 sold without required authorization.

    Medium
  17. Supergoop!

    FDA warned Supergoop! that its over-the-counter sunscreen body mousse is illegally labeled because foam dosage forms are not allowed under the sunscreen monograph.

    Medium
  18. www.mysteroidsmarket.com

    FDA warns Israel-based website mysteroidsmarket.com for selling unapproved and misbranded stimulants and benzodiazepines to U.S. consumers.

    High risk
  19. www.d-pharmacy.com

    FDA warned Singapore website d-pharmacy.com for selling unapproved prescription opioids, benzodiazepines, and stimulants to U.S. consumers.

    High risk
  20. www.portmeds.com

    FDA warned www.portmeds.com for selling unapproved, misbranded opioids, benzodiazepines, and Schedule II stimulants online without prescriptions.

    High risk
  21. www.plakini-pharma.com

    FDA warned Malaysia-based website plakini-pharma.com for selling unapproved, misbranded opioids, benzodiazepines, and stimulants to U.S. consumers.

    High risk
  22. www.buynetmeds.com

    FDA warned www.buynetmeds.com for selling unapproved, misbranded tapentadol and semaglutide drugs, including injectables, to U.S. consumers online.

    High risk
  23. www.soma4ever.com

    FDA warned soma4ever.com for selling unapproved and misbranded opioids, benzodiazepines, and stimulants to U.S. consumers online.

    High risk
  24. www.peacefulmeds.com

    FDA warned www.peacefulmeds.com for selling unapproved, misbranded opioids, benzodiazepines, and injectable semaglutide to U.S. consumers online.

    High risk
  25. www.buyprosoma.com

    FDA warned www.buyprosoma.com for selling unapproved, misbranded opioids and benzodiazepines to U.S. consumers online.

    High risk
  26. www.bigpharmausa.com

    FDA warned www.bigpharmausa.com that it sells unapproved and misbranded tramadol and oxycodone opioids to U.S. consumers online.

    High risk
  27. www.buycodeine.us

    FDA warned website buycodeine.us for selling unapproved, misbranded opioid and stimulant drugs online without prescriptions.

    High risk
  28. www.24hreup.biz

    FDA warned 24hreup.biz for selling unapproved semaglutide drugs online to U.S. consumers without prescriptions.

    High risk
  29. Shenzhen Hengkaifeng Commerce and Trade Co., Ltd

    Shenzhen Hengkaifeng's Sensitivity Toothpastes listing was inaccurate, making the drug misbranded, FDA says.

    Low
  30. FishMoxFishFlex/Simple Pet Health LLC

    FDA warned Simple Pet Health (FishMoxFishFlex) that it sells unapproved, misbranded antibiotic drugs for fish and birds online.

    High risk
  31. Amazon.com, Inc.

    Amazon sold unapproved numbing creams for tattoos and cosmetic procedures, FDA says.

    High risk
  32. Prodose, Inc. formerly known as Spirit Pharmaceuticals LLC

    Prodose, formerly Spirit Pharmaceuticals, left a cold and flu drug mislisted; FDA calls it misbranded.

    Low
  33. Naturista Store LLC

    Naturista Store sold ADVANCE KING, labeled a supplement, containing undeclared dexamethasone, diclofenac, and methocarbamol; FDA calls it an unapproved, misbranded drug.

    High risk
  34. www.thesafepills.org

    FDA warned www.thesafepills.org for selling unapproved, misbranded tapentadol opioid drugs to U.S. consumers online.

    High risk
  35. BPI Labs, LLC

    BPI Labs distributes unapproved Epinephrine Chloride Nasal Solution in a vial FDA says can be mistaken for injectable epinephrine.

    High risk
  36. USApeptide.com

    FDA warns Germany-based USApeptide.com that it sells unapproved and misbranded semaglutide and tirzepatide drugs to U.S. consumers online.

    High risk
  37. TKTX USA

    FDA warned TKTX USA that its TKTX Numbing Creams are unapproved and misbranded drugs with lidocaine levels above OTC limits.

    High risk
  38. TKTX Numb Store

    FDA warned TKTX Numb Store that its lidocaine anesthetic creams are unapproved and misbranded drugs sold without a prescription.

    High risk
  39. TKTX Store

    FDA warns TKTX Store it sells unapproved lidocaine and prilocaine numbing creams online for tattooing and cosmetic procedures.

    High risk
  40. Mihon Corp. d/b/a VitalityVita and Boulla, LLC

    FDA warns Mihon Corp./Boulla that VitalityXtra, PeakMax, ZapMax and ZoomMax supplements contain hidden sildenafil and diclofenac and are unapproved, misbranded drugs.

    High risk
  41. www.weightcrunchshop.com

    FDA warned www.weightcrunchshop.com about selling unapproved and misbranded semaglutide and oxycodone drugs to U.S. consumers online.

    High risk
  42. XO Biologix, LLC

    XO Biologix markets MaviX, an amniotic-fluid product, as an unapproved new drug and unlicensed biologic.

    High risk
  43. HDFrenchies LLC dba Bully Baum

    FDA warned HDFrenchies (Bully Baum) about selling unapproved animal drugs claimed to treat seizures and cancer.

    High risk
  44. Veronvy

    FDA warned Veronvy that its Elily Veronvy weight-loss drops are unapproved new drugs and falsely labeled "FDA APPROVED."

    Medium
  45. Dr. Brite, LLC

    FDA cited Dr. Brite for manufacturing quality failures and selling unapproved, misbranded oral care and hand sanitizer drugs.

    High risk
  46. Centura Pharmaceuticals Inc

    FDA warned Centura Pharmaceuticals that its BLT 1-2-3 Cream, a mixed numbing product for cosmetic procedures, is an unapproved new drug.

    High risk
  47. Mexicanrxpharm.com

    FDA told Mexicanrxpharm.com to stop selling unapproved, misbranded opioid pain drugs to U.S. consumers online.

    High risk
  48. Nomida.biz

    FDA warned Nomida.biz over its website selling unapproved and misbranded semaglutide and tirzepatide drugs to U.S. consumers.

    High risk
  49. MexHealth LLC d/b/a Al Natural E-Shop

    FDA warned MexHealth LLC d/b/a Al Natural E-Shop that its Ossos-Sans supplement is an unapproved, misbranded drug containing hidden diclofenac and methocarbamol.

    High risk
  50. SoloVital

    FDA says SoloVital's Umary supplement is an unapproved, misbranded drug containing hidden diclofenac and omeprazole.

    High risk